Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Alex Glavinos who wrote (1281)	2/7/1999 10:37:00 PM
From: Captain Jack	Read Replies (2) \| Respond to of 1510

Alex--- I agree it would just be nice to READ WLA's plans for the IMNR agreement with AGPH. As great as REMUNE is and will continue to be IMO they are trying to get a relationship with cancer also with the REMUNE technology. Also I believe if the arthritus med works out as expected it will be larger due to the amount of people that suffer. They have so much going for them it is a wonder they have not been bought YET.... in time I expect it though... and not a long time!